IFLR1000

GlaxoSmithKline Capital $4 billion notes issue

15/5/2018
Investment grade bond/note issue
Select tab

$ 4 billion

Announced

15/5/2018

Overview:

  • GlaxoSmithKline Capital has issued $4 billion in fixed rate notes in three tranches of fixed rate notes.

Jurisdiction:

United Kingdom

Deal type:

Investment grade bond/note issue

Practice area:

Capital markets : Debt

Industry sector:

Pharmaceuticals and life sciences

Firm:
Cleary Gottlieb Steen & Hamilton

Party: GlaxoSmithKline (Issuer)

Related deals